Plain-English translation of NCT07586618 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
United States
Phase
Safety & dosing
Sponsor
Allterum Therapeutics, Inc
Collaborators
National Cancer Institute (NCI), Cancer Prevention Research Institute of Texas
Enrollment target
~24 participants
Started
June 2026
Primary completion
May 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Shibani M Kudchadkar, MD
Baylor College of Medicine
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.